Log In
Print
BCIQ
Print
Print this Print this
 

pritelivir (AIC316)

  Manage Alerts
Collapse Summary General Information
Company AiCuris GmbH & Co. KG
DescriptionHelicase-primase inhibitor against herpes simplex virus Type 1 (HSV-1) and HSV-2
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat herpes simplex virus (HSV) infection; Treat herpes simplex virus type 1 and type 2 (HSV-2) infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today